inhibiting < inhibition < inhibitor

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]

Ident.	Authors (with country if any)	Title
000009 (2008)	Misato Hashizume [Japon] ; Masahiko Mihara [Japon]	Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
000014 (2012)	Seiji Ohtori [Japon] ; Masayuki Miyagi [Japon] ; Yawara Eguchi [Japon] ; Gen Inoue [Japon] ; Sumihisa Orita [Japon] ; Nobuyasu Ochiai [Japon] ; Shunji Kishida [Japon] ; Kazuki Kuniyoshi [Japon] ; Junichi Nakamura [Japon] ; Yasuchika Aoki [Japon] ; Tetsuhiro Ishikawa [Japon] ; Gen Arai [Japon] ; Hiroto Kamoda [Japon] ; Miyako Suzuki [Japon] ; Masashi Takaso [Japon] ; Takeo Furuya [Japon] ; Gou Kubota [Japon] ; Yoshihiro Sakuma [Japon] ; Yasuhiro Oikawa [Japon] ; Tomoaki Toyone [Japon] ; Kazuhisa Takahashi [Japon]	Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica
000017 (2011)	Katsuaki Kanbe [Japon] ; Qian Chen [États-Unis] ; Atsushi Nakamura [Japon] ; Kaori Hobo [Japon]	Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis
000022 (2011)	Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis]	Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
000023 (2009)	Misato Hashizume [Japon] ; Yasushi Uchiyama [Japon] ; Naoto Horai [Japon] ; Naohisa Tomosugi [Japon] ; Masahiko Mihara [Japon]	Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
000057 (2007)	Peter Taylor [Royaume-Uni]	IL‐6 inhibition in the treatment of rheumatoid arthritis
000069 (2016)	Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon]	Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary
000070 (2016)	Janet S. Lee [États-Unis] ; M. John Chapman [France] ; Paolo Piraino [Italie] ; Jens Lamerz [Suisse] ; Thomas Schindler [Suisse] ; Paul Cutler [Suisse] ; Gregor Dernick [Suisse]	Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin‐6 receptor‐alpha inhibition with tocilizumab
000095 (2009)	Paul Emery ; Rhonda Siddall	Tocilizumab — IL‐6 inhibition for the treatment of rheumatoid arthritis
000122 (2006)	C. Christodoulou [Royaume-Uni] ; E. H. Choy [Royaume-Uni]	Joint inflammation and cytokine inhibition in rheumatoid arthritis
000134 (2013)	F. Behrens [Allemagne] ; M. Köhm [Allemagne]	Personalisierte Medizin bei Zytokin-gerichteten Therapien
000143 (2012)	Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]	Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
000174 (2012)	M. Gaubitz [Allemagne]	Biologika 2012
000178 (2010)	G. Dückers [Allemagne] ; T. Niehues [Allemagne]	Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still)
000179 (2009)	Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto	Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody
000234 (2012)	G. Lippi [Italie] ; G. Targher [Italie]	Optimal therapy for reduction of lipoprotein(a)
000322 (2007)	M. Feuchtenberger [Allemagne] ; C. Kneitz [Allemagne] ; H.-P. Tony [Allemagne]	Zytokine
000326 (2015)	Takeshi Sainoh [Japon] ; Sumihisa Orita [Japon] ; Masayuki Miyagi [Japon] ; Yoshihiro Sakuma [Japon] ; Kazuyo Yamauchi [Japon] ; Miyako Suzuki [Japon] ; Go Kubota [Japon] ; Yasuhiro Oikawa [Japon] ; Kazuhide Inage [Japon] ; Jun Sato [Japon] ; Kazuki Fujimoto [Japon] ; Yasuhiro Shiga [Japon] ; Gen Inoue [Japon] ; Yasuchika Aoki [Japon] ; Kazuhisa Takahashi [Japon] ; Seiji Ohtori [Japon]	Interleukin‐6 and interleukin‐6 receptor expression, localization, and involvement in pain‐sensing neuron activation in a mouse intervertebral disc injury model
000364 (2013)	N. Stein [Allemagne] ; M. Witt [Allemagne] ; M. Baeuerle [Allemagne] ; H. Schulze-Koops [Allemagne] ; M. Gruenke [Allemagne]	THU0400 Inhibition of IL-6 signalling: A novel therapeutic approach for familial mediterranean fever
000504 (2013)	M. A. Cimmino ; P. Sarzi-Puttini ; S. Bombardieri [Italie] ; A. Iagnocco [Italie] ; L. Sinigaglia ; F. Debenedetti [Italie]	SAT0114 Effects Of Tocilizumab (TCZ) in Combination with Non-Biologic Dmards in the Inhibition of Progression of Synovitis, Bone Marrow Edema and Erosions Evaluated by Extremity-Dedicated Magnetic Resonance Imaging (MRI) In Rheumatoid Arthritis (RA)
000533 (2009)	E. Choy [Royaume-Uni] ; N. Sattar [Royaume-Uni]	Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "inhibition" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "inhibition" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    inhibition
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021